Invizyne Technologies Inc. Common Stock
Invizyne Technologies, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The c… Read more
Invizyne Technologies Inc. Common Stock (IZTC) - Total Liabilities
Latest total liabilities as of December 2024: $2.61 Million USD
Based on the latest financial reports, Invizyne Technologies Inc. Common Stock (IZTC) has total liabilities worth $2.61 Million USD as of December 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Invizyne Technologies Inc. Common Stock - Total Liabilities Trend (2021–2024)
This chart illustrates how Invizyne Technologies Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Invizyne Technologies Inc. Common Stock Competitors by Total Liabilities
The table below lists competitors of Invizyne Technologies Inc. Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SVENSKA CELLULO -B- - Dusseldorf Stock Exchang
DU:SCA
|
Germany | €44.40 Billion |
|
HEIWA REAL ESTATE - Dusseldorf Stock Exchang
DU:HZJ
|
Germany | €280.33 Billion |
|
Pattern Group Inc. Series A Common Stock
NASDAQ:PTRN
|
USA | $301.74 Million |
|
FOMENTO CONSTR. - Dusseldorf Stock Exchang
DU:FCC
|
Germany | €10.57 Billion |
|
Fresh Harvest Products Inc
PINK:IMTH
|
USA | $1.30 Million |
|
Portman Ridge Finance Corp
NASDAQ:PTMN
|
USA | $336.54 Million |
|
South Ocean Holdings Ltd
JSE:SOH
|
South Africa | ZAC724.65 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down Invizyne Technologies Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 8.12 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.25 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Invizyne Technologies Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Invizyne Technologies Inc. Common Stock (2021–2024)
The table below shows the annual total liabilities of Invizyne Technologies Inc. Common Stock from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $2.61 Million | -33.71% |
| 2023-12-31 | $3.94 Million | +200.26% |
| 2022-12-31 | $1.31 Million | +14.28% |
| 2021-12-31 | $1.15 Million | -- |